* Byetta LAR tops other diabetes drugs in head-to-head * Byetta better at blood glucose control, weight loss * Amylin shares up 17 percent By Bill Berkrot NEW YORK, March 31 (Reuters) - The ...

NEW YORK (Reuters) - Novo Nordisk's experimental type 2 diabetes drug, liraglutide, was superior in controlling blood sugar in a clinical trial to Eli Lilly and Co and Amylin Pharmaceuticals Inc's ...

Byetta (exenatide) is a prescription drug that’s used to treat type 2 diabetes in adults. This drug can interact with other medications and some supplements. For example, Byetta can interact with ...

June 11 -- TUESDAY, June 10 (HealthDay News) -- Diabetics getting weekly injections of an experimental long-lasting version of the drug exenatide lowered their glucose levels and lost weight over the ...

Resource4thePeople announced today that it providing consumers who are following the progress of lawsuits alleging that a class of diabetes medications including Januvia, Janumet, Byetta and Victoza ...

An experimental, once-a-week version of exenatide (Byetta) provided better glycemic control and less nausea in type 2 diabetics than the current twice-daily regimen in a recent clinical trial. The ...

Federal regulators are working on a stronger warning label for a widely used diabetes drug after new deaths were reported despite earlier warnings. The Food and Drug Administration says it has ...